Trial Radar
Sign in

NCT lookup

Pull any trial record directly from ClinicalTrials.gov.

Microbiome Metabolites and Alcohol in HIV to Reduce CVD RCT
Microbiome Metabolites and Alcohol in HIV to Reduce CVD RCT

NCT05288790

RecruitingPhase 2

Sponsor: Vanderbilt University Medical Center

Conditions: Microtia, Dysbiosis, Alcohol Drinking, HIV Infections, Cardiovascular Diseases

Interventions: Probiotic, Placebo

Countries: United States

Among people living with HIV, heavy drinking increases the risk of heart disease and death. Studies suggest that alcohol changes the number and kind of bacteria in your gut and these changes increase the risk of heart disease and death. This randomized controlled trial will determine whether a pill containing healthy gut bacteria can increase the number good bacteria in the gut, lower levels of inflammation, and lower the risk of heart disease and death.

Eligibility overview

Sex: ALL

Age: 18 Years to 89 Years

Healthy volunteers: No

Study type: INTERVENTIONAL

Eligibility criteria
Inclusion Criteria:

* HIV infected

Exclusion Criteria:

* Not fluent in English
Locations (1)
  • Nashville, Tennessee, United States